REG - Intercede Group PLC - Issue of Equity & Total Voting Rights

IntercedeAnnouncement

04/07/2024 16:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240704:nRSD2234Va&default-theme=true

RNS Number : 2234V  Intercede Group PLC  04 July 2024

4 July 2024

 

 

 

 

 

INTERCEDE GROUP plc

('Intercede', the 'Company' or the 'Group')

Issue of Equity

& Total Voting Rights

 

Intercede, the leading cybersecurity software company specialising in digital
identities, announces that it has applied for 225,000 new ordinary shares of
1p each in the capital of the Company ("Ordinary Shares") to be admitted to
trading on AIM ("Admission"). Admission is expected to occur at 8.00 a.m. on
or around 11 July 2024.

 

The new Ordinary Shares are being issued pursuant to an exercise of options,
held under the Company's Enterprise Management Incentive Plan, by an employee
of the Company. The new Ordinary Shares will rank pari passu with the
Company's existing Ordinary Shares.

 

Issue of Equity

Following Admission, the Company's issued share capital consists of 58,830,857
Ordinary Shares, each with voting rights. The Company holds 131,645 Ordinary
Shares in treasury, therefore the total number of voting rights in the Company
is 58,699,212. Accordingly, the figure of 58,699,212 may be used by
shareholders as the denominator for the calculations by which they will
determine if they are required to notify their interest in, or a change to
their interest in the Company under the FCA's Disclosure Guidance and
Transparency Rules.

Following Admission, there are total options outstanding over 3,598,205
Ordinary Shares, representing approximately 6.13% of the Company's issued
share capital.

ENQUIRIES

 Intercede Group plc                Tel. + 44 (0)1455 558111
 Klaas van der Leest                CEO
 Nitil Patel                        CFO

 Cavendish Capital Markets Limited  Tel. + 44 (0)20 7220 0500
 Simon Hicks/Fergus Sullivan        Corporate Finance
 Tim Redfern/Ondraya Swanson        Corporate Broking

 

About Intercede

Intercede is a cybersecurity software company specialising in digital
identities, and its innovative solutions enable organisations to protect
themselves against the number one cause of data breach: compromised user
credentials.

 

The Intercede suite of products allows customers to choose the level of
security that best fits their needs, from Secure Registration and ID
Verification to Password Security Management, One-Time Passwords, FIDO and
PKI. Uniquely, Intercede provides the entire set of authentication options
from Passwords to PKI, supporting customers on their journey to passwordless
and stronger authentication environments. In addition to developing and
supporting Intercede software, the Group offers professional services and
custom development capabilities as well as managing the world's largest
password breach database.

 

For over 20 years, global customers in government, aerospace and defence,
financial services, healthcare, telecommunications, cloud services and
information technology have trusted Intercede solutions and expertise in
protecting their mission critical data and systems at the highest level of
assurance.

For more information visit: www.intercede.com (http://www.intercede.com/)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  IOEBSGDRRUGDGSS